Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade
(Reuters) -Merck is acquiring UK-based Verona Pharma for about $10 billion, as part of the U.S. drugmaker's strategy to diversify ...
Read moreDetailsTag: rare diseases
Prices for new US drugs doubled in 4 years as focus on rare disease grows
By Deena Beasley (Reuters) -U.S. prices for newly-launched pharmaceuticals more than doubled last year compared to 2021, as companies leveraged ...
Read moreDetailsExclusive-Germany’s Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say
By Sabrina Valle and Patricia Weiss NEW YORK/FRANKFURT (Reuters) - Merck KGaA, the German healthcare and technology group, is in ...
Read moreDetails
